Sodium-Glucose Co-transporter Type-2 Inhibitors’ Effect on Quality of Life in Older Adult Population

Introduction The global elderly population is expanding, with chronic conditions like diabetes diminishing their quality of life. Sodium-glucose co-transporter type 2 (SGLT-2) inhibitors hold promise in improving quality of life by addressing hypervolemia, obesity, and lipid irregularities. However,...

Descripción completa

Detalles Bibliográficos
Autores principales: Tutan, Duygu, Erdoğan Kaya, Ayşe, Kayaalp, Mehmet
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Quality Improvement
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10576159/
https://www.ncbi.nlm.nih.gov/pubmed/37841994
http://dx.doi.org/10.7759/cureus.47005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10576159/
https://www.ncbi.nlm.nih.gov/pubmed/37841994
http://dx.doi.org/10.7759/cureus.47005

Ejemplares similares